Elanco Receives USDA Approval for Befrena™ Monoclonal Antibody for Canine Allergic and Atopic Dermatitis
Elanco Animal Health has received U.S. Department of Agriculture (USDA) approval for Befrena™ (tirnovetmab), an anti-IL31 monoclonal antibody injection providing long-lasting relief for dogs suffering from allergic and atopic dermatitis.